Dalid, Jerlyn T.

HRN: 06-30-59  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/28/2026
CEFAZOLIN 1GM (VIAL)
06/28/2026
06/29/2026
IV
1gm
Q8hrs X 3 Doses
S/P Primary LSTCS
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: